Table 1.
Baseline characteristics.
| Characteristics | Pre-intervention (n = 213) | Trial period (n = 52) | Post-intervention (n = 220) | Statistic | P |
|---|---|---|---|---|---|
| Age(y),mean±SD | 60.71 ± 12.63 | 60.06 ± 9.89 | 60.47 ± 11.61 | 0.069 | 0.933• |
| Male(%) | 72.77 | 76.92 | 70.45 | 0.945 | 0.623▴ |
| Smoking(%) | 64.32 | 69.23 | 56.36 | 4.453 | 0.108▴ |
| Drinking(%) | 48.36 | 50.00 | 45.45 | 0.547 | 0.761▴ |
| Hypertension(%) | 49.30 | 36.54 | 21.36* | 37.032 | < 0.001▴ |
| NIHSS,(median IQR) | 10 (6-15) | 10 (5-14) | 8 (4-12)* | 20.224 | < 0.001■ |
| PAST MEDICATIONS | |||||
| Antiplatelet(%) | 23.47 | 11.54 | 4.10* | 35.208 | < 0.001▴ |
| Anticoagulants(%) | 2.35 | 0 | 0.45 | 2.870 | 0.209▴ |
| LABORATORY DATA | |||||
| Glucose(mg/dl) | 5.85 (5.17-7.11) | 5.51 (4.88-6.64) | 5.89 (5.08-7.55) | 2.112 | 0.348■ |
| Platelet( × 103/μl) | 207 (177-239) | 203 (178-260) | 199 (156-240) | 3.996 | 0.136■ |
*
P < 0.01 vs. pre-intervention.
•
Groups were compared by SNK-q test.
■
Groups were compared by Kruskal-Wallis test.
▴
Groups were compared by χ2 test.